title: Letter by Serebruany and DiNicolantonio regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials".
authors.forename: Victor L
authors.initials: VL
authors.lastname: Serebruany
authors.forename: James J
authors.initials: JJ
authors.lastname: DiNicolantonio
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy*; D000241:Adenosine / Q000031:analogs & derivatives*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use*; D020521:Stroke / Q000188:drug therapy*; D013927:Thrombosis / Q000188:drug therapy*
chemical_list: D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D000241:Adenosine